1
Evaluation of CYT-108, a Recombinant Protease Inhibitor, for Treatment of Mild to Moderate Primary Osteoarthritis of the Knee
Condition(s):Osteoarthritis, Knee; OsteoarthritisLast Updated:February 16, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Osteoarthritis, Knee; OsteoarthritisLast Updated:February 16, 2024Not yet recruiting
Condition(s):Pain; OsteoarthritisLast Updated:August 21, 2015Unknown status
Condition(s):Diabetic Foot UlcerLast Updated:August 6, 2014Unknown status
Condition(s):Disc DiseaseLast Updated:March 2, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.